Skip to main content
Genomictree Inc. logo

Genomictree Inc. — Investor Relations & Filings

Ticker · 228760 ISIN · KR7228760005 KO Professional, scientific and technical activities
Open in API
Filings indexed 232 across all filing types
Latest filing 2026-05-19 Transaction in Own Shar…
Country KR South Korea
Listing KO 228760

About Genomictree Inc.

https://genomictree.com/eng/

Genomictree Inc. is a molecular diagnostics company that develops and commercializes products for the early detection and diagnosis of cancer. The company specializes in epigenomics, utilizing its proprietary genomic-scale discovery tools to identify DNA methylation biomarkers. Its flagship product line, EarlyTect®, offers non-invasive tests for the early screening of colorectal, lung, and bladder cancers. Additionally, Genomictree provides AccuraTect™, a companion diagnostic test for cancer. The company's mission is to improve patient quality of life and reduce medical costs through accessible and accurate early-stage cancer detection.

Recent filings

Filing Released Lang Actions
주요사항보고서(자기주식처분결정)
Transaction in Own Shares Classification · 95% confidence The document is a Korean ‘주요사항보고서(자기주식 처분 결정)’ — a major event report detailing the company’s decision to dispose treasury shares (self-share disposal) including quantities, periods, methods and related information. This directly matches the definition of “Transaction in Own Shares” (POS). It is not a simple announcement of a report (RPA) nor an earnings, management or governance document, but the substantive disclosure of a self-share transaction.
2026-05-19 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The document title and content show it is a “분기보고서” (Korean Quarterly Report) for the period January 1 to March 31, 2026 (1st quarter) with full financial statements and detailed business analysis. It is not a brief notice or link to a report, but the actual interim report itself. This matches the definition of an Interim/Quarterly Report (IR). Q1 2026
2026-05-15 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 88% confidence The document is a regulatory filing to the Financial Supervisory Service/Korea Exchange titled “사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고” (Notification of appointment, dismissal or mid-term resignation of outside directors). It details new outside director appointments, their backgrounds, and changes in board composition. This clearly falls under announcements of changes in the company’s board of directors or senior management. Therefore, it is classified as Board/Management Information (Code: MANG).
2026-03-26 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 91% confidence The document text is the official results of the company’s 2026 Annual General Meeting (정기주주총회결과), listing each agenda item, voting outcomes (approval rates, ‘가결’ or ‘미결’), and details of director and auditor appointments. This corresponds to a Declaration of Voting Results & Voting Rights Announcement at a general meeting. Therefore, it should be classified as DVA.
2026-03-26 Korean
사업보고서 (2025.12)
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report' (감사보고서) for the company 'Genomictree' (주식회사 지노믹트리). It includes the independent auditor's report, financial statements (balance sheet, income statement, statement of changes in equity, cash flow statement), and detailed notes to the financial statements. It covers the fiscal period from January 1, 2025, to December 31, 2025. This document is a comprehensive financial report and audit, fitting the definition of an Audit Report (AR). FY 2025
2026-03-18 Korean
감사보고서제출
Audit Report / Information Classification · 98% confidence The document is a formal regulatory filing titled '감사보고서 제출' (Submission of Audit Report) from the company Genomictree. It provides key financial highlights, audit opinions, and financial statements (consolidated and separate) as required by regulatory authorities. While it contains financial data, it is a summary announcement of the audit results rather than the full, multi-page annual report document itself. In the context of Korean regulatory filings (DART system), this is a standard 'Audit Report Submission' notice. FY 2025
2026-03-16 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.